NASDAQ:CASM CAS Medical Systems (CASM) Stock Price, News & Analysis → Wall Street Icon: 'I'd Put 50% of My Kids' Inheritance in THIS stock' (From Stansberry Research) (Ad) Free CASM Stock Alerts Notice: This company has been marked as potentially delisted and may not be actively trading. Add Compare Share Share Today's Range$2.44▼$2.4550-Day Range$2.45▼$2.4552-Week Range$1.06▼$2.70Volume64,728 shsAverage Volume79,750 shsMarket Capitalization$71.88 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get CAS Medical Systems alerts: Email Address Ad Stansberry ResearchWall Street Icon: "I'd Put 50% of My Kids' Inheritance in THIS stock"Wall Street Icon Warns: "A Great Financial Reset is Underway" The man CNBC called "The Prophet" predicted the 2008 housing crisis and the 2022 sell-off… Now, he says that despite the bull market, he's worried older Americans are holding the WRONG stocks in their portfolios for this stage of their lives. So, he's urging folks to buy "America's No. 1 Legacy Stock," which could help them build wealth they could pass on for generations.Learn more here. About CAS Medical Systems Stock (NASDAQ:CASM)CAS Medical Systems, Inc., a medical technology company, develops, manufactures, and markets non-invasive patient monitoring products worldwide. The company provides FORE-SIGHT tissue oximeter monitors, sensors, and accessories, as well as offers FORE-SIGHT ELITE monitors. Its FORE-SIGHT absolute tissue oximeter provides non-invasive and quantitative measurement of oxygenation for cerebral tissue during surgery or critical care situations. The company also offers repair services for parts. It markets products through its own sales force, distributors, and manufacturers' representatives, as well as through hospitals, surgery centers, and outpatient facilities. CAS Medical Systems, Inc. was founded in 1984 and is headquartered in Branford, Connecticut.Read More Ad Stansberry ResearchWall Street Icon: "I'd Put 50% of My Kids' Inheritance in THIS stock"Wall Street Icon Warns: "A Great Financial Reset is Underway" The man CNBC called "The Prophet" predicted the 2008 housing crisis and the 2022 sell-off… Now, he says that despite the bull market, he's worried older Americans are holding the WRONG stocks in their portfolios for this stage of their lives. So, he's urging folks to buy "America's No. 1 Legacy Stock," which could help them build wealth they could pass on for generations.Learn more here. CASM Stock News HeadlinesApril 17, 2024 | wsj.comInspire Medical Systems Inc.December 18, 2023 | nypost.comTop doctor says US medical system is becoming ‘unrecognizable’April 18, 2023 | health.usnews.comFirelands Regional Health System-SanduskyMarch 16, 2023 | finance.yahoo.comChina Medical System Holdings Limited (0867.HK)March 9, 2023 | forbes.comHow Can I Get A Medical Alert System For Free?July 19, 2022 | marketwatch.comCalcium Cyanamide (CAS 156-62-7) Market Share 2022 Global Business Industry Revenue, Demand and Applications Market Research Report to 2027See More Headlines Receive CASM Stock News and Ratings via Email Sign-up to receive the latest news and ratings for CAS Medical Systems and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings10/31/2018Today6/11/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical & Medical Instruments Sub-IndustryN/A Current SymbolNASDAQ:CASM CUSIPN/A CIK764579 Webwww.fore-sight.com Phone203-488-6056FaxN/AEmployees76Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.27) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-5,960,000.00 Net Margins-27.26% Pretax MarginN/A Return on EquityN/A Return on Assets-50.97% Debt Debt-to-Equity RatioN/A Current Ratio2.33 Quick Ratio2.04 Sales & Book Value Annual Sales$21.92 million Price / Sales3.28 Cash FlowN/A Price / Cash FlowN/A Book Value($0.56) per share Price / Book-4.38Miscellaneous Outstanding Shares29,340,000Free FloatN/AMarket Cap$71.88 million OptionableNot Optionable Beta0.51 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report Key ExecutivesMr. Thomas M. Patton (Age 55)Pres, CEO & Director Mr. Jeffery A. Baird (Age 65)CFO & Sec. Mr. John K. Gamelin (Age 54)VP of R&D Dr. Paul B. Benni (Age 51)Chief Scientific Officer Susan CarronDirector of Corp. CommunicationsKey CompetitorsOrchestra BioMedNASDAQ:OBIOFractyl HealthNASDAQ:GUTSAngioDynamicsNASDAQ:ANGOBeauty HealthNASDAQ:SKINInovio PharmaceuticalsNASDAQ:INOView All Competitors CASM Stock Analysis - Frequently Asked Questions How were CAS Medical Systems' earnings last quarter? CAS Medical Systems, Inc. (NASDAQ:CASM) released its earnings results on Wednesday, October, 31st. The medical technology company reported ($0.06) earnings per share for the quarter, beating the consensus estimate of ($0.07) by $0.01. The medical technology company had revenue of $5.38 million for the quarter, compared to the consensus estimate of $5.23 million. What other stocks do shareholders of CAS Medical Systems own? Based on aggregate information from My MarketBeat watchlists, some companies that other CAS Medical Systems investors own include Wells Fargo & Company (WFC), VelocityShares 3x Long Natural Gas ETN Linked to the S&P GSCI Natural Gas Index ER (UGAZ), Goldcorp (GG), VEREIT (VER), Advanced Micro Devices (AMD), Aflac (AFL), Newmont (NEM), Precigen (PGEN), Sprott Physical Gold and Silver Trust (CEF) and Magnificent Seven ETF (MAGS). This page (NASDAQ:CASM) was last updated on 6/12/2024 by MarketBeat.com Staff From Our PartnersYour Special Report - Top 7 Summer StocksSummer is almost Here! I would like to give you a special report that could help boost your portfolio this sum...StockEarnings | SponsoredThe Hidden Tax Advantages of America’s #1 Inheritance StockWall Street Millionaire: BUY "America's #1 Legacy Stock" The man CNBC called "The Prophet" bought AAPL at $...Stansberry Research | SponsoredBill Clinton Backing Biden Replacement???Louis Navellier — a frequent guest at Mar-a-Lago — ruffled many in his own circles when he declared over a yea...The Freeport Society | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredNo Strings Attached: Get 30 Days of Hedgeye’s Top Stock Picks for FreeOptimize your stock investing strategy with Hedgeye's Investing Ideas, where rigorous fundamental stock analys...Hedgeye | SponsoredHurry! Buy this stock before the Robinhood traders do!Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942...Traders Agency | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CAS Medical Systems, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CAS Medical Systems With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.